36 results on '"Strezova, Ana"'
Search Results
2. 114. Long-term Protection Against Herpes Zoster (HZ) by the Adjuvanted Recombinant Zoster Vaccine (RZV): Interim Efficacy, Immuno and Safety Results at Approximately 10 Years after Initial Vaccination
3. Higher Plasma Concentration of Food-Specific Antibodies in Persons with Autistic Disorder in Comparison to Their Siblings
4. Influence of the elevated ambient temperature on immunoglobulin G and immunoglobulin G subclasses in sera of Wistar rats
5. Long-term Protection Against Herpes Zoster by the Adjuvanted Recombinant Zoster Vaccine: Interim Efficacy, Immunogenicity, and Safety Results up to 10 Years After Initial Vaccination.
6. Association of 22 cytokine gene polymorphisms with rheumatoid arthritis in population of ethnic Macedonians
7. Association of Cytokine Gene Polymorphisms with Chronic Obstructive
8. Safety, reactogenicity and immunogenicity of a booster dose of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children
9. Association of Cytokine Gene Polymorphisms with Bronchial Asthma in Macedonians
10. Can two different pneumococcal conjugate vaccines be used to complete the infant vaccination series? A randomized trial exploring interchangeability of the 13-valent pneumococcal conjugate vaccine and the pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine
11. Long-term Protection Against Herpes Zoster (HZ) by the Adjuvanted Recombinant Zoster Vaccine (RZV): Interim Efficacy, Immuno and Safety Results at Approximately 10 Years after Initial Vaccination.
12. The adjuvanted recombinant zoster vaccine co-administered with a tetanus, diphtheria and pertussis vaccine in adults aged ≥50 years: A randomized trial
13. Immunogenicity and Safety of 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Administered to Children With Sickle Cell Disease Between 8 Weeks and 2 Years of Age
14. Safety, reactogenicity and immunogenicity of 2-dose catch-up vaccination with 10-valent pneumococcal non-typeableHaemophilus influenzaeprotein D conjugate vaccine (PHiD-CV) in Malian children in the second year of life: Results from an open study
15. Randomized, Open-Label Study of the Impact of Age on Booster Responses to the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine in Children in India
16. Safety, reactogenicity and immunogenicity of a booster dose of the 10-valent pneumococcal non-typeableHaemophilus influenzaeprotein D conjugate vaccine (PHiD-CV) in Malian children
17. Immunogenicity and Safety of 10-valent Pneumococcal Nontypeable Haemophilus influenzaeProtein D Conjugate Vaccine (PHiD-CV) Administered to Children With Sickle Cell Disease Between 8 Weeks and 2 Years of Age
18. 60. Years (1945-2005) Macedonian Medical Association
19. Ambiguities Resolution of HLA Genotypes in Macedonian Population
20. Methylenetetrahydrofolate reductase (MTHFR-677 and MTHFR-1298) genotypes and haplotypes and plasma homocysteine levels in patients with occlusive artery disease and deep venous thrombosis.
21. IL-1 Gene Cluster Polymorphisms in the Macedonian Population
22. Alpha-1-Antitrypsin Deficiency: A Case of a Two-year Old Boy with Inherited Disease
23. Sixty Years Faculty of Medicine in the Republic of Macedonia (1947-2007)
24. Association of Methylenetetrahydrofolate Reductase (MTHFR-677 and MTHFR-1298) Genetic Polymorphisms with Occlusive Artery Disease and Deep Venous Thrombosis in Macedonians
25. Safety, reactogenicity and immunogenicity of 2-dose catch-up vaccination with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children in the second year of life: Results from an open study.
26. 185-P
27. Association of HLA class I and II alleles with pulmonary tuberculosis in macedonians
28. Safety, reactogenicity and immunogenicity of 2-dose catch-up vaccination with 10-valent pneumococcal non-typeable Haemophilus influenzaeprotein D conjugate vaccine (PHiD-CV) in Malian children in the second year of life: Results from an open study
29. Randomized, Open-Label Study of the Impact of Age on Booster Responses to the 10-Valent Pneumococcal Nontypeable Haemophilus influenzaeProtein D Conjugate Vaccine in Children in India
30. Safety, reactogenicity and immunogenicity of a booster dose of the 10-valent pneumococcal non-typeable Haemophilus influenzaeprotein D conjugate vaccine (PHiD-CV) in Malian children
31. Association of cytokine gene polymorphisms with chronic obstructive pulmonary disease in Macedonians
32. 185-P: Ambiguous allele combinations at group level of HLA-A, -C, and -B genes in macedonian population using reverse line strip typing method
33. Cytokine Gene Polymorphisms in Population of Ethnic Macedonians.
34. UTICAJ POVIŠENE SPOLJAŠNJE TEMPERATURE NA IMUNOGLOBULIN G I PODGRUPE IMUNOGLOBULINA G U SERUMU PACOVA SOJA WISTAR.
35. Association of 22 cytokine gene polymorphisms with tuberculosis in Macedonians.
36. Ambiguous allele combinations at group level of HLA-A, -C, and -B genes in Macedonian population using reverse line strip typing method.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.